FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileWaldencast plc
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
WALDW
Waldencast plc Stock AnalysisComprehensive stock analysis for Waldencast plc (WALDW) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisWALDW
WALDW
Waldencast plc
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
WALDW
  1. Home
  2. Stocks
  3. Waldencast plc

Waldencast plc

🇺🇸WALDW•NASDAQ

Waldencast plc

🇺🇸WALDW•NASDAQ
Market cap
$103.98M

Your view on WALDW

Mkt Cap
$103.98M
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Waldencast plc

Industry
Household & Personal Products
Sector
Consumer Defensive
CEO
Michel Brousset
Headquarters
81 Fulham Road, London, NY, GB
Industry
Household & Personal Products
Sector
Consumer Defensive
CEO
Michel Brousset
Headquarters
81 Fulham Road, London, NY, GB
Description

Waldencast plc specializes in sophisticated skincare solutions, offering advanced treatments designed to diminish the appearance of premature aging, alleviate skin damage, correct hyperpigmentation, manage acne, and mitigate the effects of sun exposure.

These products are predominantly distributed through a professional network that includes dermatologists, plastic surgeons, medical spas, and other certified skincare experts.

The company's portfolio features Obagi Medical, a line of transformative skincare products formulated to visibly reduce signs of aging, target issues such as dark spots, uneven pigmentation, fine lines, and wrinkles, while simultaneously safeguarding and enhancing overall skin tone and texture.

Additionally, Obagi Clinical provides skincare offerings specifically developed to proactively prevent the onset of early aging symptoms. Established in 1988, the company is based in White Plains, New York.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Waldencast plc. Starting points for Waldencast plc: EPS -$1.40, beta -0.04 — an Household & Personal Products name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Waldencast plc. Trailing twelve-month EPS for Waldencast plc stands at -$1.40. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Wall Street analysts· not FRC research
Nov 22, 2026
More →

Earnings per share estimates

Per shareThis quarterDec 2026Next quarterJun 2027This yearYear to Dec 2026Next yearYear to Dec 2027
Average estimate$0.01$0.01−$0.50−$0.44
Lowest estimate$0.01$0.01−$0.50−$0.44
Highest estimate$0.01$0.01−$0.50−$0.44
Number of analysts1111
A year ago−$0.291−$0.09−$2.011—
Growth vs a year ago—+107.4%——

1The year-ago figure includes one-time items, so growth is not shown.

Revenue estimates

TotalThis quarterDec 2026Next quarterJun 2027This yearYear to Dec 2026Next yearYear to Dec 2027
Average estimate$65.97M$47.78M$286.57M$317.57M
Lowest estimate$65.97M$47.78M$286.57M$317.57M
Highest estimate$65.97M$47.78M$286.57M$317.57M
Number of analysts1111
A year ago$142.29M$132.27M$272.07M—
Growth vs a year ago−53.6%−63.9%+5.3%—

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Waldencast plc. Waldencast plc has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold WALDW19 companies
Compare WALDW with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustryMkt cap
APCXAppTech Payments Corp.TechnologySoftware - Infrastructure$19.8M
AUUDAuddia Inc.TechnologySoftware - Application$1.0M
BIYABaiya International Group Inc. Ordinary SharesIndustrialsStaffing & Employment Services$3.3M
BOXLBoxlight CorporationTechnologyConsumer Electronics$563,863
COE51Talk Online Education GroupConsumer DefensiveEducation & Training Services$58.0M
MASK3 E Network Technology Group Ltd Class A Ordinary SharesTechnologyInformation Technology Services$5.6M
MYSZMy Size, Inc.TechnologySoftware - Application$1.0M
More Household & Personal Products companies
TickerTypeCompanySectorExchangeMkt cap
PZCUYPZ Cussons plcConsumer DefensiveOTC$316.7M
RBCLRBC Life Sciences, Inc.Consumer DefensiveOTC$1,328
RBGLYReckitt Benckiser Group plcConsumer DefensiveOTC$58.1B
RBGPFReckitt Benckiser Group plcConsumer DefensiveOTC$54.7B
REYNReynolds Consumer Products Inc.Consumer DefensiveNASDAQ$5.1B
RPHCFRohto Pharmaceutical Co.,Ltd.Consumer DefensiveOTC$3.7B
RWMIRegalWorks Media, Inc.Consumer DefensiveOTC$539,280
S66.AXStar Combo Pharma LimitedConsumer DefensiveASX—
SKINThe Beauty Health CompanyConsumer DefensiveNASDAQ$76.7M
SKN.AXSkin Elements LimitedConsumer DefensiveASX—
SLSNSolesence, Inc. Common StockConsumer DefensiveNASDAQ$99.6M
SNBHSentient Brands Holdings Inc.Consumer DefensiveOTC$2.3M
Open Comparable Analysis
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold Waldencast plc, and how their positions are changing. At a $104.0M market value, institutional positions materially move Waldencast plc's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Waldencast plc executives and directors. Shares of Waldencast plc have traded between $0.02 and $0.86 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Waldencast plc. Coverage tracks Waldencast plc within Household & Personal Products (Consumer Defensive). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Waldencast plc.

WALDW AnalysisFair
Past
1
Growth
5
Health
4
Profit
1
Value
1